Treatment for viral diseases

What is Arexvy?

The US Food and Drug Administration (FDA) has approved the world’s first respiratory syncytial virus vaccine called Arexvy. The vaccine, manufactured by British pharmaceutical company GSK, has been approved for individuals aged 60 years and above in the United States. ..



COVID-19: World Bank offers 1 billion USD for India’ Emergency Response Project

On April 1, 2020, the World Bank announced that it is to offer 1 billion USD to Government of India to implement Covid-19 Emergency Response and Health Systems preparedness project. About the Project The project is being launched by India ..


FDA approves Convalescent Plasma Treatment for seriously ill COVID-19 patients

The Food and Drug Administration of the United States has approved the use of Convalescent plasma collected from patients recovered from COVID-19 to treat seriously ill COVID-19 patients. The idea of the method is to inject plasma with antibodies into ..


HydroxyChloroquine now made a H1 Drug in India; Exports banned

On March 27, 2020, the Ministry of Health and Family Welfare declared the Hydroxycholoroquine as a Schedule H1 drug. With this GOI has brough upon restrictions on sales and distribution of the drug. Highlights The Hydroxychloroquine drug was declared as ..


Four Mega Trials of COVID-19 Treatment launched by WHO

The World Health Organization recently launched a mega trial of four most promising corona virus treatments. The organization focuses on repurpose drugs that have already been approved to be safe rather than finding new compounds from the scratch. What are ..


New Hanta Virus Emerges in China after COVID-19

A man in Yunnan Province of China has tested positive for Hanta Virus. He died shortly after he was tested positive for the virus on March 23, 2020. The symptoms of Hanta Virus are similar to that of the Corona ..